145,018 Shares in First Trust Nasdaq Pharmaceuticals ETF $FTXH Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 145,018 shares of the company’s stock, valued at approximately $6,014,000. Oppenheimer & Co. Inc. owned about 0.55% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in FTXH. Englebert Financial Advisers LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at approximately $751,000. Cyndeo Wealth Partners LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at approximately $1,524,000. Trust Co. of Oklahoma bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the third quarter worth $1,283,000. MinichMacGregor Wealth Management LLC bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the third quarter worth $968,000. Finally, Flagship Harbor Advisors LLC grew its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 50.9% during the third quarter. Flagship Harbor Advisors LLC now owns 8,500 shares of the company’s stock worth $352,000 after buying an additional 2,868 shares during the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of NASDAQ:FTXH opened at $43.25 on Thursday. The company has a fifty day moving average of $41.60 and a 200-day moving average of $37.09. The company has a market capitalization of $1.15 billion, a PE ratio of 14.51 and a beta of 0.45. First Trust Nasdaq Pharmaceuticals ETF has a 52-week low of $29.40 and a 52-week high of $43.52.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Thursday, September 24th were issued a dividend of $0.0113 per share. This is a negative change from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. The ex-dividend date of this dividend was Thursday, September 24th. This represents a $0.05 annualized dividend and a dividend yield of 0.1%.

First Trust Nasdaq Pharmaceuticals ETF Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.